Meanwhile, analysis of surrogate biomarkers in blood is becoming a feasible strategy to aid in early diagnosis of TSE, given that total PrP and total tau levels have been already correlated with CJD [250,251]. The gene discussed is MAPT; the disease is Creutzfeldt Jacob disease.